Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TTR | P02766 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | TPMT | P51580 | 1/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6912796 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6908473 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6908477 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6914818 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6910009 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6914812 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6912723 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6915188 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6915193 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 | |
| SCHEMBL6918699 | 0.98 | PTGER4 (0.52) | PTGER4CYP1A2CYP2A6ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109725088-B | Gas chromatography-mass spectrometry combined method for measuring 2-naphthoic acid and derivatives thereof in bean sprouts | 丁立平 | 2021-05-18 | — | — | CN | claimed |
| CN-110540552-A | Aromatic phosphorus oxide compound and preparation method of aromatic phosphorus oxide medicine thereof | UNIV HUNAN | 2019-12-06 | — | — | CN | claimed |
| CN-109725088-A | The gas chromatography-mass spectrometry of 2- naphthoic acid and its derivative in a kind of measurement bean sprouts | 丁立平 | 2019-05-07 | — | — | CN | claimed |
| EP-4562017-A1 | NOVEL ACC INHIBITORS | Pfizer Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-120019059-A | Novel ACC inhibitors | 辉瑞公司 | 2025-05-16 | — | — | CN | disclosed |
| US-20240109915-A1 | NOVEL ACC INHIBITORS | PFIZER INC. (US) | 2024-04-04 | — | — | US | disclosed |
| WO-2024023727-A1 | NOVEL ACC INHIBITORS | PFIZER INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| CN-108699003-B | Catalytic hydrogenation process for preparing pyrazoles | 巴斯夫欧洲公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-3230339-B1 | EPOXY RESIN COMPOSITION, PREPREG, FIBER-REINFORCED PLASTIC MATERIAL, AND MANUFACTURING METHOD FOR FIBER-REINFORCED PLASTIC MATERIAL | TORAY INDUSTRIES (JP) | 2022-03-23 | — | — | EP | disclosed |
| CN-109725088-B | Gas chromatography-mass spectrometry combined method for measuring 2-naphthoic acid and derivatives thereof in bean sprouts | 丁立平 | 2021-05-18 | — | — | CN | disclosed |
| CN-109725088-B | Gas chromatography-mass spectrometry combined method for measuring 2-naphthoic acid and derivatives thereof in bean sprouts | 丁立平 | 2021-05-18 | — | — | CN | disclosed |
| EP-1246895-A1 | FUEL COMPOSITION | ExxonMobil Research and Engineering Company (US) | 2002-10-09 | — | — | EP | disclosed |
| WO-2001044415-A1 | FUEL COMPOSITION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2001-06-21 | — | — | WO | disclosed |
| EP-0492841-B1 | Anti-herpes castanospermine esters | MERRELL DOW PHARMA (US) | 1995-08-16 | — | — | EP | disclosed |
| US-5385911-A | Potent inhibitors of glycoprotein processing enzymes | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-01-31 | — | — | US | disclosed |
| EP-0297534-B1 | Castanospermine esters and glycosides | MERRELL DOW PHARMA (US) | 1994-12-28 | — | — | EP | disclosed |
| EP-0492841-A1 | Anti-herpes castanospermine esters | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-07-01 | — | — | EP | disclosed |
| US-5017563-A | Antidiabetic | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-05-21 | — | — | US | disclosed |
| EP-0309952-A2 | Anti-retroviral castanospermine esters | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-04-05 | — | — | EP | disclosed |
| EP-0297534-A2 | Castanospermine esters and glycosides | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109915-A1 | NOVEL ACC INHIBITORS | CBR3, NAT1, ACACB | PTGER4 3827/4885CYP1A2 1279/4885CYP2A6 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.